In a special city council meeting held on September 29, 2025, the Bartlesville City Council discussed a critical resolution regarding participation in a settlement with Purdue Pharma and several pharmaceutical companies. The resolution, numbered 3748, aims to secure funds for the city as part of a broader settlement related to the opioid crisis.

City Attorney Jess Cain presented the resolution, explaining that the city had received late notice of the settlement due to an incorrect email address. This oversight prompted the urgent meeting, as the deadline to file a claim was set for September 30. Cain emphasized the importance of acting quickly to ensure Bartlesville could benefit from the settlement, although he admitted he had limited information about the specifics of the case or the potential financial outcomes.

The resolution would authorize the mayor and a designated representative to execute necessary documents for the city's participation in the settlements with various pharmaceutical companies, including Albojem Inc., Amneal Pharmaceuticals, and others. Cain noted that the settlement still requires approval from the bankruptcy court, which adds uncertainty to the process.

Council members expressed their concerns and questions regarding the implications of the settlement and how any potential funds would be utilized within the community. The urgency of the situation highlighted the city's need to act swiftly to secure financial support that could address local issues stemming from the opioid crisis.

As the council deliberated, the focus remained on the potential benefits for Bartlesville residents, emphasizing the importance of timely action in navigating the complexities of the settlement process. The council's decision will play a significant role in determining how the city can leverage these funds to support community health and recovery efforts in the future.